perform
pneumovir
system
luminex
xtag
rvp
fast
assay
detect
common
respiratori
virus
upper
lower
tract
respiratori
specimen
n
uniqu
patient
influenzalik
syndrom
lower
tract
respiratori
infect
nest
pcr
coupl
autom
sequenc
use
resolut
discrep
fulli
concord
result
obtain
total
specimen
wherea
specimen
gave
partial
n
fulli
discord
n
result
kappa
coeffici
overal
specif
luminex
xtag
rvp
fast
assay
slightli
higher
pneumovir
assay
human
bocaviru
influenza
influenza
b
viru
human
metapneumoviru
parainfluenza
viru
wherea
sensit
latter
higher
target
virus
except
notabl
picornavirus
irrespect
either
origin
respiratori
specimen
age
group
patient
belong
acut
respiratori
tract
infect
caus
respiratori
virus
rv
common
infect
attend
hospit
primari
care
center
rang
mild
selflimit
ill
sever
diseas
latter
particularli
pediatr
sever
immunosuppress
patient
ison
hayden
renaud
great
divers
rv
produc
clinic
indistinguish
symptom
thu
laboratori
diagnosi
base
simultan
detect
multipl
target
becom
best
option
etiolog
diagnosi
molecular
method
increasingli
use
diagnosi
respiratori
viral
infect
due
fine
sensit
specif
time
turnov
progress
replac
convent
method
caliendo
decis
choos
one
molecular
system
complex
requir
systemat
compar
evalu
context
luminex
xtag
rvp
fast
assay
luminex
molecular
diagnost
austin
tx
usa
extens
evalu
recent
year
compar
studi
also
publish
show
high
reliabl
detect
rv
differ
clinic
set
babadi
et
al
dabischruth
et
al
gadsbi
et
al
hwang
et
al
jokela
et
al
krunic
et
al
merant
et
al
pabbaraju
et
al
pabbaraju
et
al
pillet
et
al
popowitch
et
al
rand
et
al
raymaek
et
al
pneumovir
assay
genomica
coslada
spain
revers
transcriptionpolymeras
chain
reaction
rtpcr
dna
microarray
method
make
possibl
detect
simultan
rv
reliabl
procedur
detect
rv
children
adult
previous
shown
culebra
et
al
frobert
et
al
pillet
et
al
renoi
et
al
tokman
et
al
nevertheless
littl
known
system
compar
multiplex
platform
current
studi
perform
characterist
pneumovir
assay
compar
xtag
rvp
fast
assay
detect
rv
clinic
specimen
children
adult
influenzalik
syndrom
lower
tract
respiratori
infect
retrospect
studi
includ
total
nonconsecut
upper
n
lower
tract
n
respiratori
specimen
obtain
uniqu
patient
receiv
microbiolog
servic
hospit
ramon
cajal
madrid
hospit
universitario
tabl
throat
nasopharyng
swab
collect
flock
swab
univers
transport
medium
beckton
dickinson
spark
md
usa
copan
diagnost
murrieta
ca
usa
remain
type
specimen
transport
undilut
case
specimen
receiv
laboratori
within
min
collect
conserv
process
within
h
recept
nucleic
acid
extract
perform
use
qiagen
viral
extract
kit
robot
instrument
qiagen
valencia
ca
usa
hospit
universitario
method
madrid
spain
hospit
cajal
follow
routin
diagnost
protocol
establish
center
accord
manufactur
instruct
nucleic
acid
extract
platform
valid
luminex
xtag
rvp
fast
assay
manufactur
packag
insert
wwwluminexcorpcomassaysxtagrvp
likewis
method
previous
valid
use
coupl
pneumovir
assay
frobert
et
al
pillet
et
al
turn
qiagen
viral
extract
kit
valid
manufactur
person
commun
group
unpublish
result
manual
nucleic
acid
extract
purif
method
recommend
manufactur
packag
insert
sampl
volum
use
nucleic
acid
extract
platform
respect
method
use
isopropanol
solvent
nucleic
acid
elut
volum
kit
respect
leftov
specimen
nucleic
acid
extract
conserv
investig
initi
test
laboratori
perform
luminex
xtag
rvp
fast
assay
frozen
nucleic
acid
extract
store
maximum
month
thaw
test
pneumovir
assay
either
origin
specimen
store
new
extract
frozen
nucleic
acid
extract
avail
use
analyz
discrep
order
determin
whether
longterm
storag
repeat
freez
thaw
maximum
cycl
effect
rv
detect
randomli
select
nucleic
acid
extract
subject
nest
pcr
sequenc
analysi
discrep
reanalyz
luminex
xtag
rvp
fast
assay
pneumovir
assay
reanalys
gave
similar
result
obtain
previous
luminex
xtag
rvp
fast
assay
use
current
studi
assay
nucleic
acid
sampl
convert
complementari
dna
mix
short
sequenc
tag
primer
dna
specif
viral
target
target
present
primer
bind
lengthen
process
call
target
specif
primer
extens
extens
label
incorpor
colorcod
bead
ad
identifi
tag
primer
attach
differ
color
bead
antitag
sequenc
specif
extend
tag
primer
antitag
bind
complementari
tag
sequenc
primer
sampl
place
luminex
instrument
bead
read
analyz
laser
laser
identifi
color
bead
specif
viru
subtyp
presenc
absenc
label
primer
phage
genom
ssrna
size
nt
ad
specimen
serv
control
nucleic
acid
extract
effici
intern
posit
control
bacteriophag
lambda
ad
amplif
reaction
control
rtpcr
effici
rtpcr
perform
accord
xtag
rvp
fast
assay
product
insert
instruct
templat
volum
unocycl
thermocycl
vwr
intern
bvba
leuv
belgium
rtpcr
follow
singlestep
hybrid
pcr
product
fluoresc
bead
array
incub
report
reagent
plate
analyz
use
xmap
instrument
luminex
molecular
diagnost
toronto
canada
use
xponent
softwar
luminex
xtag
rvp
fast
assay
allow
detect
adenoviru
adv
human
bocaviru
hbov
human
coronaviru
hcov
season
influenza
viru
infa
infa
virus
nonsubtypific
influenza
b
viru
infb
human
metapneumoviru
hmpv
b
parainfluenza
viru
piv
respiratori
syncyti
viru
rsv
ab
enterovirusrhinoviru
evrh
pneumovir
dna
array
assay
genomica
coslada
spain
perform
interpret
follow
manufactur
recommend
assay
base
amplif
specif
fragment
bp
viral
genom
mean
multiplex
pcr
rtpcr
pcr
rtpcrpcr
amplif
amplifi
product
label
biotin
follow
amplif
hybrid
specif
probe
immobil
site
microarray
perform
incub
streptavidinperoxidis
conjug
addit
tetramethylbenzidin
result
appear
insolubl
product
precipit
hybrid
site
microarray
hybrid
profil
read
clinic
array
reader
interpret
mean
pneumovir
softwar
amplif
reaction
perform
unocycl
thermocycl
vwr
intern
bvba
use
templat
volum
intern
control
ad
amplif
reaction
specifi
manufactur
pneumovir
dna
array
assay
differ
luminex
xtag
rvp
fast
assay
detect
influenza
c
viru
allow
detect
alphacoronaviru
viru
betacoronavirus
pneumovir
abl
discrimin
rhinoviru
enteroviru
genu
permit
identif
new
influenza
discrep
method
resolv
mean
inhous
develop
nest
pcr
assay
direct
sequenc
amplicon
follow
previous
publish
protocol
coira
et
al
coira
et
al
et
al
viral
agent
miss
either
one
assay
target
analysi
discord
henc
presenc
viral
agent
detect
system
confirm
nest
pcr
coupl
sequenc
distinguish
fulli
partial
discord
result
former
refer
qualit
discrep
posit
one
method
neg
assay
viru
detect
differ
assay
latter
assay
coincid
least
viru
although
assay
could
identifi
virus
full
concord
defin
obtain
ident
result
method
includ
neg
result
true
posit
defin
either
posit
ident
result
assay
singl
assay
confirm
correspond
hous
rtpcr
assay
coupl
direct
sequenc
agent
includ
pneumovir
panel
detect
luminex
xtag
rvp
fast
hcov
exclud
compar
analys
pairwis
differ
sensit
determin
mcnemar
test
p
valu
consid
signific
level
agreement
assay
calcul
mean
kappa
statist
among
respiratori
specimen
initi
includ
studi
posit
luminex
xtag
rvp
assay
human
cov
includ
pneumovir
panel
cov
n
cov
n
cov
n
exclud
analys
describ
thu
final
number
sampl
includ
compar
purpos
total
number
virus
detect
luminex
xtag
rvp
fast
assay
pneumovir
compar
n
versu
n
respect
p
likewis
method
perform
compar
detect
multipl
infect
n
versu
n
respect
p
fulli
concord
obtain
total
specimen
ident
posit
result
sampl
yield
neg
result
assay
thu
overal
rate
concord
kappa
coeffici
singl
rv
detect
specimen
yield
concord
posit
result
two
rv
detect
sampl
partial
fulli
discord
result
observ
sampl
sampl
respect
latter
discrep
result
correspond
specimen
test
neg
one
method
posit
specimen
test
posit
method
yield
differ
viral
agent
note
infa
detect
pneumovir
specimen
specimen
test
either
neg
n
posit
infa
n
luminex
xtag
rvp
fast
assay
detail
descript
discrep
result
shown
tabl
tabl
show
number
viral
agent
detect
method
excel
concord
kappa
index
found
hmpv
rsv
convers
suboptim
concord
kappa
index
found
infa
picornavirus
evrh
data
clearli
prove
superior
luminex
xtag
rvp
fast
assay
pneumovir
assay
detect
picornavirus
p
contrast
pneumovir
method
appear
perform
slightli
better
detect
rv
includ
panel
although
differ
reach
statist
signific
tabl
perform
assay
irrespect
either
origin
respiratori
specimen
age
group
patient
belong
data
shown
total
specimen
yield
discord
result
analyz
nest
pcr
coupl
autom
sequenc
suffici
volum
analysi
avail
remain
specimen
viral
agent
miss
either
one
multiplex
pcr
assay
confirm
refer
method
specimen
remain
specimen
presenc
viral
agent
respiratori
specimen
detect
one
method
could
confirm
refer
method
thu
consid
falseposit
result
tabl
follow
resolut
discrep
data
indic
sensit
luminex
xtag
rvp
fast
assay
higher
pneumovir
assay
detect
picornavirus
versu
opposit
true
adv
vs
hbov
versu
infb
versu
infa
infa
hmpv
rsv
ab
number
avail
specimen
confirm
nest
pcr
coupl
sequenc
current
studi
perform
characterist
commerci
avail
multiplex
pcr
assay
detect
rv
pneumovir
assay
luminex
xtag
rvp
fast
assay
compar
note
version
longer
avail
market
assay
compar
handson
time
time
result
slightli
longer
pneumovir
assay
approxim
h
versu
h
data
indic
follow
overal
degre
concord
assay
kappa
coeffici
discuss
mostli
due
discrep
detect
picornavirus
sens
luminex
xtag
rvp
fast
assay
clearli
superior
p
b
pneumovir
assay
ii
sensit
pneumovir
assay
higher
luminex
xtag
rvp
fast
assay
target
agent
except
notabl
picornavirus
contrast
overal
specif
latter
assay
slightli
higher
pneumovir
assay
rv
result
highli
concord
kappa
index
hmpv
rsv
wherea
strike
discrep
observ
infa
picornavirus
iii
perform
assay
compar
irrespect
origin
specimen
upper
versu
lower
respiratori
tract
age
patient
pediatr
versu
adult
patient
line
data
pillet
et
al
found
pneumovir
assay
display
better
overal
sensit
luminex
xtag
rvp
fast
assay
mostli
due
increas
rate
detect
influenza
virus
special
infb
adv
hbov
suboptim
sensit
luminex
xtag
rvp
fast
assay
detect
adv
hbov
infa
virus
infb
rsv
ab
comparison
commerci
platform
esensor
rvp
filmarray
rvp
also
report
babadi
et
al
popowitch
et
al
contrari
pneumovir
poorli
sensit
detect
picornavirus
also
report
studi
pillet
et
al
tokman
et
al
may
like
due
fact
assay
detect
enteroviru
type
b
pillet
et
al
falseposit
result
scarc
frequent
obtain
pneumovir
assay
especi
hbov
piv
notabl
context
mix
infect
misprim
like
reason
account
falseposit
result
nevertheless
given
high
overal
sensit
pneumovir
rule
possibl
true
posit
remain
undetect
nest
pcr
assay
employ
resolut
discrep
contrast
previous
publish
data
pillet
et
al
tokman
et
al
use
differ
criteria
resolv
discord
result
among
studi
may
account
discrep
limit
current
studi
rel
scarc
number
posit
specimen
sever
viral
agent
retrospect
design
impli
use
thaw
instead
freshli
obtain
specimen
test
pneumovir
assay
context
also
inher
bia
associ
select
archiv
specimen
compar
studi
addit
due
financi
constraint
detect
given
target
method
consid
trueposit
result
without
test
refer
method
despit
limit
data
prove
reliabl
pneumovir
assay
compar
luminex
xtag
rvp
fast
assay
diagnosi
upper
lower
tract
respiratori
infect
adult
pediatr
patient
